Clinical trials
Not yet recruiting Phase 1 Carcinoma, Renal Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AccSalus Biosciences, Inc. | 1 |
| Jian Lin | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Liangyou Gu | 1 |
| Norroy Bioscience Co., LTD | 1 |
| Peking University First Hospital | 1 |
| UTC Therapeutics Inc. | 1 |
| Zhejiang University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 9 |
| Neoplasm Metastasis | 2 |
| Carcinoma, Hepatocellular | 1 |
| Gallbladder Neoplasms | 1 |
| Melanoma | 1 |
| Myofibroma | 1 |
| Nasopharyngeal Carcinoma | 1 |
| Ovarian Neoplasms | 1 |
| Recurrence | 1 |
| Squamous Cell Carcinoma of Head and Neck | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.